La registrazione del dominio è in attesa. Controlla di nuovo tra un'ora
Dott. Davide Lazzeroni
Ambulatorio Cardiologico - Parma
Via Goffredo Mameli, 5, Parma PR
Testimonianze
un anno fa
- Riccardo GUn medico straordinario sia per competenza che per un grande senso di umanità nei confronti del paziente Un grazie di cuore
2 anni fa
- Rodolfo VMedico molto competente, sensibile e attento all’ascolto del paziente
4 mesi fa
- Giuseppe APerfetto
Cardiologo
Ambulatorio cardiologico
Cardiologo clinico con esperienza scientifica in ambito di:
1) Cardiomiopatie - malattie primitive del miocardio - patologie genetiche - malattie rare in cardiologia - Cardiomiopatia Ipertrofica
2) Cuore d’atleta e valutazioni cardiologiche in giovani atleti
3) Aritmie ventricolari e rischio di morte improvvisa.
4) Malattie del Microcircolo coronarico
5) Prevenzione Cardiovascolare primaria e secondaria.
6) Ipertensione arteriosa
7) rapporto cuore-mente:
- S. di Takotsubo (Cardiomiopatia da Stress)
- Analisi del sistema nervoso autonomo
8) Cardiopatia Ischemia - post-infarto
9) Scompenso cardiaco
9) Valvulopatie
Cardiologo clinico con esperienza scientifica in ambito di:
1) Cardiomiopatie - malattie primitive del miocardio - patologie genetiche - malattie rare in cardiologia - Cardiomiopatia Ipertrofica
2) Cuore d’atleta e valutazioni cardiologiche in giovani atleti
3) Aritmie ventricolari e rischio di morte improvvisa.
4) Malattie del Microcircolo coronarico
5) Prevenzione Cardiovascolare primaria e secondaria.
6) Ipertensione arteriosa
7) rapporto cuore-mente:
- S. di Takotsubo (Cardiomiopatia da Stress)
- Analisi del sistema nervoso autonomo
8) Cardiopatia Ischemia - post-infarto
9) Scompenso cardiaco
9) Valvulopatie
PRESTAZIONI EFFETTUATE:
- Visita cardiologica
- Elettrocardiogramma
- Ecocolordoppler Cardiaco
- Ecocolordoppler Tronchi Sovra-aortici
- Test da sforzo (opzionale)
Prenotazioni al numero: +39 327 5546360
Mail: davide.lazzeroni@gmail.com
------------------------------------------------------------------
CURRICULUM STUDIORUM
- 24/10/2006: Laurea in Medicina e Chirurgia con voto 110/110 e lode.
- 02/08/2011: Laurea Specialistica in Cardiologia con voto 50/50 e lode.
------------------------------------------------------------------
ELENCO PUBBLICAZIONI SCIENTIFICHE
D Lazzeroni, et al. Red Blood Cell Distribution Width: a powerful predictive marker of adverse outcomes after myocardial revascularization or cardiac valve surgery. Nature Scientific Reports 2021 Jan (accepted for publication)
D Lazzeroni,et al. Trabecular complexity as an early marker of cardiac involvement in Fabry disease. Eur Heart J Cardiovasc Imaging. 2021 Jan 22:jeaa354. doi: 10.1093/ehjci/jeaa354. 2020
D Lazzeroni, Concari P, Moderato L. Simultaneous COVID-19 in Monozygotic Twins. Ann Intern Med. 2020 Dec 8:L20-1207. doi: 10.7326/L20-1207. Online ahead of print.
D Lazzeroni, et al. Relationship between aortic stiffness and cardiorespiratory fitness in primary and secondary cardiovascular prevention patients. Eur J Prev Cardiol. 2020
D Lazzeroni, et al. In-hospital day-by-day systolic blood pressure variability during rehabilitation: a marker of adverse outcome in secondary prevention after myocardial revascularization.. Journal of Hypertension 2020
D Lazzeroni,et al. Trabecular complexity as an early marker of cardiac involvement in Fabry disease. Eur Heart J Cardiovasc Imaging. 2021 Jan 22:jeaa354. doi: 10.1093/ehjci/jeaa354. 2020
D Lazzeroni, Concari P, Moderato L. Simultaneous COVID-19 in Monozygotic Twins. Ann Intern Med. 2020 Dec 8:L20-1207. doi: 10.7326/L20-1207. Online ahead of print.
D Lazzeroni, et al. Relationship between aortic stiffness and cardiorespiratory fitness in primary and secondary cardiovascular prevention patients. Eur J Prev Cardiol. 2020
D Lazzeroni, et al. In-hospital day-by-day systolic blood pressure variability during rehabilitation: a marker of adverse outcome in secondary prevention after myocardial revascularization.. Journal of Hypertension 2020
D Lazzeroni, et al.Mitochondrial Energetics and Ca2+-Activated ATPase in Obstructive Hypertrophic Cardiomyopathy. Journal of Clinical Medicine 9 (6), 1799. 2020.
D Lazzeroni, et al. Takotsubo Syndrome
During SARS-CoV-2 Pneumonia: A PossibleCardiovascular
Complication Giornale italiano di
cardiologia. 21 (6), 417-420; 2020.
D Lazzeroni,
et al. Cardiopulmonary exercise testing for personalized job
reintegration after acute cardiovascular attacks:
a pilot cross-sectional study. La Medicina del lavoro 111 (2),
107-115. 2020
D Lazzeroni, et
al. Bridging the gap between hypertrabeculation phenotype,
noncompaction phenotype and left ventricular noncompaction
cardiomyopathy. Journal of
Cardiovascular Medicine 2020
D Lazzeroni et al.
Delta mapse: an easy-to-use tool to evaluate coronary artery
stenosis during dypiridamole pharmacological stress
echocardiography. European Heart
Journal-Cardiovascular Imaging 21 (Supplement_1), jez319. 976
D Lazzeroni et al. Prevention
and Rehabilitation European Heart
Journal Supplements 21 (Supplement_J), J196-J198. 2019
D Lazzeroni et al. Arterial Hypertension European
Heart Journal Supplements 21 (Supplement_J), J32-J34 2019
D Lazzeroni. Health literacy in
cardiovascular prevention:‘From small things, big things
come’. European journal of
preventive cardiology, 2047487319888812. 2019
D Lazzeroni, et
al. Septal Late Gadolinium Enhancement and Arrhythmic Risk in
Genetic and Acquired Non-ischaemic
Cardiomyopathies Heart, Lung and
Circulation 2019.
D Lazzeroni,
et al. Prognostic role of education
levels after cardiac surgery and
in hospital cardiac rehabilitation. European Journal of Preventive
Cardiology, 20474873198828151. 2019
D Lazzeroni,
et al.4951 Long-term prognostic value of adherence to leisure
time physical
activity prescription in patients
undergoing exercise-based cardiac rehabilitation: an inverse
dose. European Heart Journal 40 (Supplement_1), ehz746. 0021
2019
D Lazzeroni,
et al.P5273 Trabecular complexity as a subclinical structural
alteration in Fabry
cardiomyopathy: a cardiac magnetic
resonance study. European Heart Journal 40 (Supplement_1), ehz746.
0244. 2019
D Lazzeroni, et al. 1177 Insights on mitochondrial
energetics inobstructive hypertrophic cardiomyopathy M European
Heart Journal 40 (Supplement_1), ehz748. 0019 . 2019
D Lazzeroni,
et al. IN HOSPITAL DAY-BY-DAY BLOOD
PRESSURE VARIABILITY: A MARKER OF
ADVERSE OUTCOME IN SECONDARY CARDIOVASCULAR PREVENTION..Journal
of Hypertension 37, e79. 2019
D Lazzeroni, et
al.P620 Mitral annular plane systolic excursion on cardiac magnetic
resonance imaging as a predictor of atrial fibrillation
in hypertrophic
cardiomyopathy. European Heart
Journal-Cardiovascular Imaging 20 (Supplement_2), jez116. 023. 2019
D Lazzeroni, et al. 551
Trabecular complexity as a subclinical structural alteration
in fabry cardiomyopathy:
a cardiac magnetic resonance study. al. European Heart
Journal-Cardiovascular Imaging 20 (Supplement_2), jez125. 002. 2019
D Lazzeroni, et
al PERCEIVED ANXIETY, EMOTIVE TENSION, COPING STRATEGIES AND
AUTONOMIC FUNCTION IN TAKOTSUBO
SYNDROME LONG AFTER THE ACUTE
PHASE.. EUROPEAN HEART JOURNAL SUPPLEMENTS 21 (E), E66-E66
2019.
D Lazzeroni, et al. PROGNOSTIC ROLE OF EDUCATIONAL
ATTAINMENT AFTER EXERCISE-BASED CARDIAC
REHABILITATIONEUROPEAN HEART JOURNAL SUPPLEMENTS 21 (E), E66-E68.
2019.
Lazzeroni D, et al.. Serum uric acid level
predicts adverse outcomes after myocardial revascularization or
cardiac valve surgery.. Eur J Prev Cardiol. 2018 Jan;25(2):119-126.
doi: 10.1177/2047487317744045.
Davide Lazzeroni, et al. Prognostic
value of frontal QRS-T angle in
patients undergoing myocardial revascularization or cardiac valve
surgery. Journal of Electrocardiology 51 (2018) 967–972.
Lazzeroni D.
Prediction of cardiovascular events using risk scores
or electrocardiogram: A
farewell to arms. Eur J Prev Cardiol. 2018 Jan;25(1):76-77. doi:
10.1177/2047487317739416.
Lazzeroni D, et
al Regarding Article, "Persistent Long-Term Structural,
Functional, and Metabolic Changes After
Stress-Induced (Takotsubo) Cardiomyopathy"..Circulation.
2018 Aug 28;138(9):960-961. doi: 10.1161/CIRCULATIONAHA.117.033253.
Lazzeroni D, et
al. Risk stratification in secondary
cardiovascular prevention. Minerva
Cardioangiol. 2018 Aug;66(4):471-476. doi:
10.23736/S0026-4725.18.04648-0. Epub 2018
Lazzeroni D, et
al. Anxiety disorders and stressful events in Takotsubo
syndrome. Cardiol J.
2018;25(4):495-500. doi: 10.5603/CJ.a2017.0136.
D Lazzeroni, et
al. P1937 The MyrhythmTM app for automatic detection of atrial
fibrillation using commercial chest strap monitors: proof-of-concept
accuracy testing in patients undergoing external. European
Heart Journal 39 (suppl_1), ehy565. P1937
Lazzeroni D, et
al.Multifractal multiscale dfa of cardiovascular time series:
Differences in complex dynamics of systolic blood pressure,
diastolic blood pressure and heart rate. Conf Proc IEEE Eng Med Biol
Soc. 2017 Jul;2017:3477-3480.
Lazzeroni D, et al.Predictive role of P-wave
axis abnormalities in secondary cardiovascular
prevention. Eur J Prev Cardiol. 2017 Jan
1:2047487317734892.
D Lazzeroni,
et al. SODIUM SENSITIVITY AND
INVERSE SODIUM SENSITIVITY IN NORMOTENSIVE AND HYPERTENSIVE
INDIVIDUALS..Journal of Hypertension 35,
e89. 2017
D Lazzeroni,
et al.P4509 Incremental value of CMR-derived mitral annular plane
systolic excursion for atrial fibrillation risk stratification in
patients with hypertrophic
cardiomyopathy European Heart
Journal 38 (suppl_1)2017.
D Lazzeroni, et
al.Cardiotoxicity in oncology and coronary
microcirculation: future challenges in
theranostics. Frontiers in bioscience (Landmark edition)
22 (3/4), 1760-1773 5 2017.
D Lazzeroni, et
al. Theranostic biomarkers in hypertrophic
cardiomyopathy: insights in a long
road ahead.. Frontiers in bioscience (Landmark edition) 22
(1), 1724-1749 1.2017
D Lazzeroni, et
al. Calcium channel blockade blunts the renal effects of acute
nitric oxide synthase inhibition in healthy humans. American Journal
of Physiology-Renal Physiology 312 (5), F870-F878 2 2017
D Lazzeroni,
et al.Autonomic function in Takotsubo
syndrome long after the acute
phase. International journal of cardiology 231, 222-224 10 2017
D Lazzeroni,
et al. Improvement in aerobic capacity during cardiac
rehabilitation in coronary artery
disease patients: is there a role for autonomic
adaptations? European journal of preventive cardiology 24 (4),
357-364
D Lazzeroni et
al. Prognostic role of stress echocardiography in hypertrophic
cardiomyopathy: the International
Stress Echo Registry. International journal of cardiology 219,
331-338,18.2016.
D Lazzeroni,
et al Hemodynamic and autonomic response to different salt
intakes in normotensive individuals. P. Journal
of the American Heart Association 5 (8), e003736.10.201</di
Galleria
Messaggio inviato. Ti risponderemo a breve.